Retrospective analysis of hospital admissions due to immune checkpoint inhibitor-induced immune-related adverse events (irAE).
Elizabeth AhernMichael J AllenAndrew L SchmidtZarnie LwinBrett G M HughesPublished in: Asia-Pacific journal of clinical oncology (2020)
A sum of 11% patients receiving ICI required hospital admission for irAE. The relatively high rate of irAE as a missed differential diagnosis on admission suggests a need for improved cross-discipline awareness, education, and institutional management guidelines.